{"cluster": 64, "subcluster": 17, "abstract_summ": "We find that the RBD of the spike protein of SARS-CoV-2 is highly optimized to achieve very strong binding with human ACE2 (hACE2) which is consistent with its enhanced infectivity.The major hot spot amino acids involved in the binding identified by interaction analysis after simulations includes Glu 35, Tyr 83, Asp 38, Lys 31, Glu 37, His 34 amino acid residues of ACE2 receptor and Gln 493, Gln 498, Asn 487, Tyr 505 and Lys 417 residues in nCoV S-protein RBD.Notably, the SARS-CoV-2 RBD out-competes the angiotensin 2 receptor type I (ATR1) which is the native binding partner of ACE2 by 35% in terms of the calculated binding affinity.By contrasting the spike protein SARS-CoV-2 Rosetta binding energy with ACE2 of different livestock and pet species we find strongest binding with bat ACE2 followed by human, feline, equine, canine and finally chicken.Using homology modeling and molecular dynamics (MD) simulation methods, we report here the detailed structure of the ACE2 in complex with the receptor binding domain (RBD) of the SARS-CoV-2 spike protein.", "title_summ": "An exploration of the SARS-CoV-2 spike receptor binding domain (RBD) \u2013 a complex palette of evolutionary and structural featuresComputational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike proteinDynamics of the ACE2 - SARS-CoV/SARS-CoV-2 spike protein interface reveal unique mechanismsBiophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivityStructural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptorCrystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptorCritical Differences between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoVStructure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.", "title_abstract_phrases": "An exploration of the SARS-CoV-2 spike receptor binding domain (RBD) \u2013 a complex palette of evolutionary and structural featuresSARS-CoV-2 spike protein (S) is associated with the entry of virus inside the host cell by recruiting its loop dominant receptor binding domain (RBD) and interacting with the host ACE2 receptor.Biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivitySARS-CoV-2 is a novel highly virulent pathogen which gains entry to human cells by binding with the cell surface receptor \u2013 angiotensin converting enzyme (ACE2).We find that the RBD of the spike protein of SARS-CoV-2 is highly optimized to achieve very strong binding with human ACE2 (hACE2) which is consistent with its enhanced infectivity.Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike proteinA novel coronavirus (the SARS-CoV-2) has been identified in January 2020 as the causal pathogen for COVID-19 pneumonia, an outbreak started near the end of 2019 in Wuhan, China.Notably, the SARS-CoV-2 RBD out-competes the angiotensin 2 receptor type I (ATR1) which is the native binding partner of ACE2 by 35% in terms of the calculated binding affinity."}